Concise total synthesis of botryolide B

Debendra K. Mohapatra*a, Gonela Umamaheshwara, M. Mallikarjuna Raoa, Deivasigamani Umadevib and Jhillu S. Yadava
aNatural Products Chemistry Division, CSIR-Indian Institute of Chemical Technology, Tarnaka, Hyderabad-500007, India. E-mail: mohapatra@iict.res.in; Fax: +91-40-27193128; Tel: +91-40-27193128
bCentre for Molecular Modelling, CSIR-Indian Institute of Chemical Technology, Tarnaka, Hyderabad-500007, India. Fax: +91-40-27193128; Tel: +91-40-27193128

Received 19th August 2013 , Accepted 2nd December 2013

First published on 4th December 2013


Abstract

An efficient total synthesis of botryolide B was achieved in 9 longest linear steps with 22% overall yield via esterification of a carboxylic acid with an alcohol fragment and a ring closing metathesis (RCM) reaction as pivotal steps to construct the macrolactone ring system. Our novel approach for the synthesis of the 2-alkene-1,5-diol fragment was achieved by a ring closing metathesis reaction followed by a reductive opening strategy, whereas the carboxylic acid fragment was accessed from commercially available (R)-(+)-α-hydroxy-γ-butyrolactone in three steps.


Introduction

Many naturally occurring ten-membered lactones isolated from fungal metabolites, commonly known as decanolides, have attracted considerable attention from synthetic organic chemists as well as bioorganic chemists, because of their interesting structural features and various biological activities such as plant growth inhibition, antifeedant, antifungal, and antibacterial activities.1 All decanolides shown in Fig. 1 posses some common interesting structural features; the olefinic moiety with well defined geometry as well as stereochemically pure hydroxyl appendages make them very challenging synthetic targets. In 2007, Gloer and co-workers isolated botryolide B from the cultures of a funiculus isolate of Botryotrichum sp. (NRRL 38180).2 Very recently, Meshram and co-workers as well as Radha Krishna and co-workers reported the total synthesis of botryolide B employing a ring-closing metathesis (RCM) reaction to construct the macrolide with a cis double bond.3
image file: c3ra44478c-f1.tif
Fig. 1 Structures of some epoxide containing decanolides.

As part of our ongoing research program exploring the ring closing metathesis4 reaction for macrolide synthesis, we investigated the scope of the RCM5 reaction for the most concise total synthesis of botryolide B.

According to our retrosynthetic analysis as shown in Scheme 1, we envisioned a convergent strategy for the target molecule 2 via the assembly of late stage intermediates 11 and 12, which could be realized by Yamaguchi esterification followed by a ring-closing metathesis (RCM) reaction. Intermediate 11 could be conveniently accessed from the inexpensive starting material propylene oxide while carboxylic acid fragment 12 could be prepared from commercially available (R)-(+)-α-hydroxy-γ-butyrolactone in three steps. Our idea for the generation of highly enantioenriched 2-alkene-1,5-diol was via a ring-closing metathesis reaction followed by reductive opening of an α,β-unsaturated δ-lactone moiety in a highly concise manner.


image file: c3ra44478c-s1.tif
Scheme 1 Retrosynthetic analysis of botryolide B.

Results and discussion

The synthesis of fragment 11 began by the kinetic resolution of racemic propylene oxide under Jacobsen's reaction conditions, using the (R,R)-N,N′-bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediaminocobalt(II) catalyst to give the chiral epoxide 14 (98% ee).6 Treatment of epoxide 14 with vinylmagnesium bromide in the presence of CuI in diethyl ether at −78 °C to −40 °C for 6 h afforded homoallyl alcohol 17.7 As the product had a low boiling point, without silica gel column purification, the alcohol was acetylated with acryloyl chloride to furnish diene 18 in 78% yield over two steps (Scheme 2). Ring-closing metathesis of acryloyl ester 18 was achieved smoothly with 10 mol% of Grubbs 1st generation catalyst under refluxing conditions in CH2Cl2 for 8 h to furnish 13 in 89% yield.8 2-Alkene-1,5-diol 19 was prepared from α,β-unsaturated δ-lactone moiety 13 in 88% yield by a DIBAL-H reduction.9 Sharpless asymmetric epoxidation of 19 with (−)-DIPT, Ti(iPrO)4 and TBHP in CH2Cl2 gave the epoxide 20 with the required stereoisomerism in 82% yield.10 Conversion of epoxy alcohol into 11 was accomplished in good yield by the oxidation of epoxy alcohol with BAIB/TEMPO in CH2Cl2 followed by one carbon homologation with PPh3CH3Br and NaHMDS in THF at −10 °C (75% over two steps).11
image file: c3ra44478c-s2.tif
Scheme 2 Reagents and conditions: (a) CH2[double bond, length as m-dash]CHMgBr, CuI, THF, −78 °C to −40 °C, 6 h; (b) acryloyl chloride, Et3N, 0 °C, 6 h, 78% over two steps; (c) Grubbs' 1st generation catalyst, CH2Cl2, reflux, 8 h, 89%; (d) DIBAL-H, 0 °C, 1 h, 88%; (e) (−)-DIPT, Ti(iPrO)4, TBHP, CH2Cl2, −20 °C, 48 h, 82%; (f) (1) BAIB/TEMPO, CH2Cl2, 0 °C–rt, 1 h and (2) PPh3CH3Br, NaHMDS, THF, −10 °C, 2 h, 75% over two steps.

The synthesis of the carboxylic acid fragment started with commercially available (R)-(+)-α-hydroxy-γ-butyrolactone. Intermediate 15 was prepared from the known TBS-protected (R)-(+)-α-hydroxy-γ-butyrolactone 21 (ref. 12) in 80% yield by a convenient one-pot procedure, involving a DIBAL-H reduction followed by one carbon homologation (Scheme 3).4e The primary alcohol 15 was converted to acid 12 (ref. 13) by BAIB/TEMPO in CH3CN[thin space (1/6-em)]:[thin space (1/6-em)]H2O (9[thin space (1/6-em)]:[thin space (1/6-em)]1) to afford acid 12 in 91% yield.14


image file: c3ra44478c-s3.tif
Scheme 3 (a) TBSCl, imidazole, DMF, 0 °C, 3 h, 99%; (b) (i) DIBAL-H, −78 °C and (ii) PPh3CH3Br, n-BuLi, THF, −78 °C to −10 °C, 2 h, 80%; (c) BAIB/TEMPO, CH3CN[thin space (1/6-em)]:[thin space (1/6-em)]H2O (9[thin space (1/6-em)]:[thin space (1/6-em)]1), 91%, 3 h.

Having synthesized 11 and 12, we proceeded further with their coupling and the ring closing metathesis reaction. Coupling of the two fragments 11 and 12 was achieved under Yamaguchi conditions15 using 2,4,6-trichlorobenzoyl chloride to furnish diene ester 10 in 84% yield. This set the stage for the crucial ring closing metathesis (path A), which was successfully achieved with Grubbs' 2nd generation catalyst (0.001 M dilution in degassed CH2Cl2 under reflux conditions afforded the lactone 26 with a Z-configured olefin as the exclusive product) (Scheme 4) (74% yield). Deprotection of TBS-ether with TBAF in CH2Cl2 led to the formation of the target botryolide B (2) in 92% yield. Similarly, through path B, initial deprotection of the silyl ether group using TBAF in THF followed by ring-closing metathesis under the same reaction conditions also afforded botryolide B in 78% yield (exclusively Z-isomer). The constitution and configuration of the assigned structure was unambiguous since the spectroscopic and analytical data were in excellent accord with the proposed structure and perfectly matched those reported in the literature.2 In addition, density functional theory calculations have been done to compare the stability of the E- and Z-isomers of the botryolide B. The structures of the isomers were optimized without any constraints by employing the B3LYP/6-31G* basis set. They were characterised as minima on the potential energy surface by the frequency calculations. All the calculations were performed using the G09 programme package.16 The results indicate that the Z-isomer is more stable than the E-isomer as observed experimentally (Fig. 2).


image file: c3ra44478c-s4.tif
Scheme 4 (a) 2,4,6-Trichlorobenzoyl chloride, Et3N, DMAP, THF, toluene, 0 °C, 4 h, 84%; (b) Grubbs' 2nd generation catalyst, CH2Cl2, reflux, 8 h, (path A = 74%, path B = 78%); (c) TBAF, THF, 0 °C–rt, 2 h, (path A = 92%, path B = 93%).

image file: c3ra44478c-f2.tif
Fig. 2 Optimized geometries and relative energies (kcal mol−1) of the E- and Z-isomers of the botryolide B at B3LYP/6-31G* level.

Conclusions

In summary, an efficient total synthesis of botryolide B was achieved in 9 longest linear steps with 22% overall yield following Yamaguchi esterification of carboxylic acid and alcohol fragments followed by a ring closing metathesis reaction as key steps to construct the ten-membered macrolactone. The 2-alkene-1,5-diol fragment was achieved by ring-closing metathesis followed by reductive opening strategy, whereas the carboxylic acid fragment was accessed from commercially available (R)-(+)-α-hydroxy-γ-butyrolactone in a concise manner.

Experimental section

General remarks

Air- and/or moisture-sensitive reactions were carried out in anhydrous solvents under an atmosphere of argon in oven- or flame-dried glassware. All anhydrous solvents were distilled prior to use: THF, benzene, toluene and diethyl ether from Na and benzophenone; CH2Cl2, quinoline and Et3N from CaH2; MeOH and EtOH from Mg cake. Commercial reagents were used without purification. Column chromatography was carried out on silica gel (60–120 mesh). Infrared spectra were recorded in CHCl3/neat (as mentioned) and are reported in wavenumbers (cm−1). 1H and 13C NMR chemical shifts are reported in ppm downfield from tetramethylsilane (TMS), and coupling constants (J) are reported in Hertz (Hz). The following abbreviations are used to designate signal multiplicity: s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet, br. = broad.

(R)-Pent-4-en-2-yl acrylate (18)

A round-bottomed flask was charged with copper(I) iodide (654 mg, 3.4 mmol) and anhydrous THF (20 mL) was added to it. The resulting suspension was cooled to −78 °C with vigorous stirring and then vinylmagnesium bromide (1 M in THF, 68.1 mL, 68.1 mmol) was injected into the mixture. A solution of propylene oxide 14 (2.0 g, 34.07 mmol) in THF (10 mL) was added slowly to the reaction and the mixture was stirred for 6 h at −40 °C. After completion of the reaction (monitored by TLC), it was quenched with saturated aqueous NH4Cl solution (20 mL). The reaction mixture was diluted with ethyl acetate (40 mL) and the organic layer separated. The aqueous layer was extracted with ethyl acetate (2 × 40 mL). The combined organic layers were washed with brine (75 mL), dried (Na2SO4) and concentrated under reduced pressure to afford the crude homoallylic alcohol 17 (2.93 g) which was used for the next reaction without further purification.

To a stirred solution of the allylic alcohol 17 (2.93 g, 34.06 mmol) in CH2Cl2 (30 mL) at 0 °C, was added NEt3 (14.7 mL, 102.1 mmol) followed by acryloyl chloride (5.5 mL, 8.13 mmol). The reaction mixture was warmed to room temperature and stirred overnight. After completion of the reaction (monitored by TLC), it was quenched with saturated aqueous NH4Cl solution (30 mL). The organic layer was separated and the aqueous layer extracted with CH2Cl2 (3 × 40 mL). The combined organic layer was washed with saturated aqueous brine (100 mL), dried (MgSO4), and concentrated under reduced pressure. The crude product was purified by silica gel column chromatography (ethyl acetate[thin space (1/6-em)]:[thin space (1/6-em)]hexane = 1[thin space (1/6-em)]:[thin space (1/6-em)]4) to obtain diene 18 (3.72 g, 78%) as a colorless oil. [α]25D −189.3 (c 1.2, CHCl3); IR (neat): 2978, 2929, 1725, 1695, 1390, 1252, 1109, 1055 cm−1; 1H NMR (300 MHz, CDCl3): 6.38 (dd, J = 1.5, 17.3 Hz, 1H), 6.12 (dd, J = 10.3, 17.3 Hz, 1H), 5.84–5.7 (m, 2H), 5.12–5.01 (m, 3H), 2.42–2.3 (m, 2H), 1.26 (d, J = 6.4 Hz, 3H); 13C NMR (75 MHz, CDCl3): 165.4, 133.2, 130.2, 128.6, 117.5, 69.1, 39.8, 19.1; MS (ESI): m/z = 217 [M + H]+.

(R)-6-Methyl-5,6-dihydro-2H-pyran-2-one (13)

To a solution of diene 18 (1.5 g, 10.56 mmol) in degassed CH2Cl2 (1000 mL), was added Grubbs' first generation catalyst (863 mg, 1.05 mmol) at room temperature. The reaction mixture was stirred for 8 h at the same temperature. After completion of the reaction (monitored by TLC), the solvent was removed under reduced pressure. The resulting residue was then redissolved in a 10[thin space (1/6-em)]:[thin space (1/6-em)]1 hexane–ethyl acetate solvent mixture and filtered through a short pad of silica gel. The solvent was removed under reduced pressure and the crude product was purified by silica gel column chromatography (ethyl acetate[thin space (1/6-em)]:[thin space (1/6-em)]hexane = 2[thin space (1/6-em)]:[thin space (1/6-em)]3) to afford the lactone 13 (1.06 g, 89%) as a pale yellow liquid. [α]25D −196.2 (c 1.7, EtOH); IR (neat): 2924, 2854, 1725, 1456, 1271, 1195 cm−1; 1H NMR (300 MHz, CDCl3): 6.91 (dt, J = 3.0, 9.8 Hz, 1H), 6.04 (d, J = 9.8 Hz, 1H), 4.66 (m, 1H), 2.39–2.30 (m, 2H), 1.45 (d, J = 6.0 Hz, 3H); 13C NMR (75 MHz, CDCl3): 164.4, 145.1, 120.8, 74.2, 30.7, 20.4; HRMS (ESI) m/z calcd for C6H9O2: [M + H]+ 113.0597, found 113.0599.

(R,Z)-Hex-2-ene-1,5-diol (19)

To a stirred solution of the lactone 13 (1.0 g, 8.92 mmol) in anhydrous CH2Cl2 (30 mL) at 0 °C under nitrogen, was added DIBAL-H (15.9 mL, 1.4 M in CH2Cl2, 22.3 mmol) and the mixture was stirred for 2 h. It was warmed to room temperature and stirred for an additional 30 min. The reaction was quenched with 2 N HCl (25 mL) at 0 °C and the organic layer was separated. The aqueous layer was extracted with CH2Cl2 (2 × 30 mL). The combined organic layer was washed with water (60 mL), brine (60 mL), dried over Na2SO4 and concentrated. The residue was purified by silica gel column chromatography (ethyl acetate[thin space (1/6-em)]:[thin space (1/6-em)]hexane = 3[thin space (1/6-em)]:[thin space (1/6-em)]2) to furnish 19 (0.9 g, 88%) as a colorless liquid. [α]25D −22.1 (c 2.3, CHCl3); IR (KBr) νmax: 3441, 2930, 2892, 2857, 1737, 1253, 1100, 1039 cm−1; 1H NMR (300 MHz, CDCl3): 5.88 (dt, J = 7.3, 10.8 Hz, 1H), 5.69 (m, 1H), 4.21 (dd, J = 7.3, 19.3 Hz, 1H), 4.12 (dd, J = 6.8, 19.3 Hz, 1H), 3.87 (m, 1H), 2.21–2.39 (m, 2H), 1.24 (d, J = 6.2 Hz, 3H); 13C NMR (75 MHz, CDCl3): 131.4, 129.3, 66.8, 57.7, 31.9, 23.1; MS (ESI): m/z = 117 [M + H]+.

(R)-1-((2S,3R)-3-(Hydroxymethyl)oxiran-2-yl)propan-2-ol (20)

To a stirred solution of (−)-DIPT (0.32 mL, 1.55 mmol) in CH2Cl2 (40 mL) at −20 °C containing 4 Å molecular sieves (1.0 g), were added sequentially Ti(OiPr)4 (0.61 mL, 2.06 mmol) and t-butyl hydroperoxide (5.16 mL, 33.6 mmol) and stirred for 20 min. A solution of 19 (600 mg, 5.17 mmol) in CH2Cl2 (10 mL) was added and stirred for 48 h at −20 °C. After completion of the reaction (monitored by TLC), it was quenched with 20% NaOH solution (25 mL). The reaction mixture was stirred for 3 h and the organic layer separated. The aqueous layer was extracted with CH2Cl2 (2 × 30 mL). The combined organic layer was dried (Na2SO4) and concentrated under reduced pressure. The residue obtained was purified by silica gel column chromatography (ethyl acetate[thin space (1/6-em)]:[thin space (1/6-em)]hexane = 3[thin space (1/6-em)]:[thin space (1/6-em)]2) to furnish 20 (559 mg, 82%) as a colorless liquid. [α]25D −32.2 (c 2.2, CHCl3); IR (neat): 3423, 2923, 2858, 1611, 1513, 1363, 1247, 1032 cm−1; 1H NMR (300 MHz, CDCl3): 4.18 (m, 1H), 3.86 (m, 1H), 3.52 (m, 1H), 2.38–2.13 (m, 2H), 1.42–1.52 (m, 2H), 1.23 (d, J = 5.3 Hz, 3H); 13C NMR (75 MHz, CDCl3): 68.0, 62.7, 57.7, 42.0, 38.8, 21.9; MS (ESI): m/z = 155.2 [M + Na]+.

(R)-1-((2S,3R)-3-Vinyloxiran-2-yl)propan-2-ol (11)

To a solution of 20 (400 mg, 3.03 mmol) in CH2Cl2 (20 mL) were added TEMPO (90 mg, 0.6 mmol) and BAIB (1.17 g, 3.6 mmol). After stirring at 0 °C for 2 h, the reaction mixture was diluted with CH2Cl2 (15 mL) and then washed with saturated aqueous Na2S2O3 (2 × 20 mL). The organic layer was dried over Na2SO4 and concentrated under reduced pressure. The crude product was passed through a small bed of silica gel (ethyl acetate[thin space (1/6-em)]:[thin space (1/6-em)]hexane = 1[thin space (1/6-em)]:[thin space (1/6-em)]4) to afford the epoxy aldehyde (400 mg) as a colorless liquid, which was used as such without further purification.

To a solution of (methylenetriphenyl)phosphonium bromide (6.59 g, 18.4 mmol) in anhydrous THF (70 mL), NaHMDS (15.3 mL, 1 M, 15.3 mmol) was added at −10 °C and the mixture was stirred for 1 h. Aldehyde (400 mg, 3.07 mmol) in anhydrous THF (4 mL) was added at −10 °C and the reaction mixture was stirred for an additional 2 h. After completion of the reaction (monitored by TLC), it was quenched with saturated NH4Cl (30 mL) solution. The reaction mixture was diluted with ethyl acetate (50 mL) and the organic layer was separated. The aqueous layer was extracted with ethyl acetate (2 × 50 mL). The combined extracts were washed with brine (70 mL), dried (Na2SO4) and concentrated under reduced pressure. The crude residue was purified by silica gel column chromatography (ethyl acetate[thin space (1/6-em)]:[thin space (1/6-em)]hexane = 1[thin space (1/6-em)]:[thin space (1/6-em)]3) to afford 11 (290.9 g, 75%) as a colorless liquid. [α]25D −9.1 (c 1.0, CHCl3); IR (neat): 2950, 2923, 1733, 1461, 1261, 1111, 772 cm−1; 1H NMR (300 MHz, CDCl3): 5.72 (m, 1H), 5.47 (d, J = 17.5 Hz, 1H), 5.36 (d, J = 10.9 Hz, 1H), 4.07 (m, 1H), 3.46 (dd, J = 4.4, 10.9 Hz, 1H), 3.28 (dt, J = 4.4, 7.6 Hz, 1H), 1.76–1.61 (m, 2H), 1.27 (d, J = 6.5 Hz, 3H); 13C NMR (75 MHz, CDCl3): 132.3, 120.5, 65.9, 56.9, 55.9, 36.7, 23.7; HRMS (ESI) m/z calcd for C7H12O2Na: [M + Na]+ 151.0729, found 151.0726.

(R)-3-(tert-Butyldimethylsilyloxy)dihydrofuran-2(3H)-one (21)

To a stirred solution of 16 (0.5 g, 4.9 mmol) in DMF (30 mL) was added imidazole (496 mg, 7.3 mmol) followed by TBSCl (1.1 g, 7.3 mmol) at 0 °C. The resulting mixture was then stirred for 3 h at room temperature. After completion of the reaction, the mixture was quenched by the addition of water (15 mL), diluted with Et2O (3 × 20 mL), washed with brine, dried over anhydrous Na2SO4 and concentrated under reduced pressure. Purification of the crude compound by column chromatography afforded TBS ether 21 (1.04 g, 99%) as a colorless oil. [α]25D +35.4 (c 1.8, CHCl3); IR (neat): 2954, 2932, 1721, 1656, 1612, 1513, 1465 cm−1; 1H NMR (300 MHz, CDCl3): 4.45–4.35 (m, 2H), 4.21 (t, J = 9.0 Hz, 1H), 2.48 (m, 1H), 2.25 (m, 1H), 0.92 (s, 9H), 0.18 (s, 3H), 0.15 (s, 3H); 13C NMR (CDCl3, 75 MHz): 175.9, 68.2, 64.7, 32.3, 25.6, 18.2, −4.7, −5.3; MS (ESI): m/z = 217.6 [M + H]+.

(R)-3-(tert-Butyldimethylsilyloxy)pent-4-en-1-ol (15)

To a solution of 21 (0.6 g, 2.77 mmol) in anhydrous CH2Cl2 (20 mL) was added a 1.4 M solution of DIBAL-H in toluene (1.97 mL, 2.7 mmol) at −78 °C and the mixture was stirred for 30 min at −78 °C. The reaction was quenched with methanol (1.0 mL) and saturated aqueous sodium potassium tartrate solution (10 mL). The mixture was stirred at room temperature for 2 h to obtain two clear layers. The organic layer was separated and the aqueous layer extracted with CH2Cl2 (2 × 25 mL). The combined organic layers were dried over Na2SO4 and concentrated under reduced pressure to obtain the crude lactol (0.6 g) which was used as such for the next reaction without further purification.

To a suspension of methyltriphenylphosphonium bromide (3.94 g, 11 mmol) in anhydrous THF (40 mL) maintained at 0 °C under an argon atmosphere was added a 1.6 M solution of n-BuLi in hexane (5.15 mL, 8.25 mmol), and the mixture was stirred for 30 min at 0 °C. The mixture was then cooled to −78 °C, and a solution of lactol (0.6 g, 2.75 mmol) in THF (6 mL) was added. The mixture was stirred for 2 h at room temperature, and the reaction was quenched with a saturated solution of NH4Cl (25 mL). The mixture was extracted with ethyl acetate (3 × 40 mL). The combined organic extracts were washed with saturated brine (75 mL), dried over anhydrous Na2SO4 and concentrated under reduced pressure. The crude product was purified by silica gel column chromatography (ethyl acetate[thin space (1/6-em)]:[thin space (1/6-em)]hexane = 1[thin space (1/6-em)]:[thin space (1/6-em)]4) to obtain 15 (480 mg, 80%) as a colorless liquid. [α]25D +4.2 (c 1.0, CHCl3); IR (neat): 2954, 2857, 1613, 1513, 1249, 1091 cm−1; 1H NMR (300 MHz, CDCl3): 5.77 (dt, J = 10.3, 17.3 Hz, 1H), 5.05 (d, J = 10.3 Hz, 2H), 3.9 (dt, J = 10.3, 6.4 Hz, 1H), 3.83 (m, 1H), 3.73 (m, 1H), 1.82–1.75 (m, 2H), 0.92 (s, 9H), 0.06 (s, 3H), 0.03 (s, 3H); 13C NMR (CDCl3, 75 MHz): 140.5, 114.3, 73.0, 59.9, 39.0, 25.7, 18.0, −4.4, −5.1; MS (ESI): m/z = 217.5 [M + H]+.

(R)-3-(tert-Butyldimethylsilyloxy)pent-4-enoic acid (12)

To a solution of alcohol 15 (400 mg, 1.85 mmol) in CH3CN[thin space (1/6-em)]:[thin space (1/6-em)]H2O (9[thin space (1/6-em)]:[thin space (1/6-em)]1, 4.0 mL) were added TEMPO (55 mg, 0.37 mmol) and BAIB (1.19 g, 3.7 mmol). After stirring at room temperature for 2 h, the reaction mixture was diluted with CH2Cl2 (5 mL) and then washed with saturated aqueous Na2S2O3 (10 mL). The organic layer was dried over Na2SO4 and filtered, and the filtrate was concentrated under reduced pressure to give the crude carboxylic acid, which was further purified by flash column chromatography (ethyl acetate[thin space (1/6-em)]:[thin space (1/6-em)]hexane = 1[thin space (1/6-em)]:[thin space (1/6-em)]4) to furnish acid 12 (387 mg, 91%) as a colorless oil. [α]25D −7.1 (c 1.8, CH2Cl2); IR (neat): 2956, 2858, 1785, 1714, 1219, 927, 835, 773 cm−1; 1H NMR (300 MHz, CDCl3): 5.85 (m, 1H), 5.26 (d, J = 16.9 Hz, 1H), 5.12 (d, J = 9.9 Hz, 1H), 4.58 (m, 1H), 2.55 (d, J = 9.9 Hz, 2H), 0.89 (s, 9H), 0.08 (s, 3H), 0.07 (s, 3H); 13C NMR (75 MHz, CDCl3): 176.0, 139.5, 115.2, 77.4, 70.5, 4.1, 25.7, −4.4, −5.2; HRMS (ESI) m/z calcd for C11H22O3NaSi: [M + Na]+ 253.1230, found 253.1227.

(R)-((R)-1-((2S,3R)-3-Vinyloxiran-2-yl)propan-2-yl)-3-(tert-butyldimethylsilyloxy)pent-4-enoate (10)

To a stirred solution of acid 12 (287 mg, 1.25 mmol) in anhydrous THF (20 mL) were added 2,4,6-trichlorobenzoyl chloride (0.25 mL, 1.56 mmol) and Et3N (0.27 mL, 1.87 mmol) and the contents were stirred at 0 °C temperature. After 2 h, DMAP (153 mg, 1.25 mmol) and a solution of alcohol 11 (80 mg, 0.625 mmol) in THF (10 mL) were added and the reaction mixture was stirred for 4 h at room temperature. The reaction was quenched with water (15 mL) and diluted with ethyl acetate (30 mL). The organic layer was separated and the aqueous layer extracted with ethyl acetate (2 × 30 mL). The combined organic layers were washed with saturated NaHCO3 (50 mL) and brine (50 mL), dried over (Na2SO4) and evaporated under reduced pressure. The crude residue was purified by column chromatography on silica gel (ethyl acetate[thin space (1/6-em)]:[thin space (1/6-em)]hexane = 1[thin space (1/6-em)]:[thin space (1/6-em)]5) to afford 10 (179 mg, 84%) as a colorless liquid. [α]25D −12.5 (c 1.4, CHCl3); IR (neat): 2928, 2856, 1737, 1219, 1082, 927, 772 cm−1; 1H NMR (300 MHz, CDCl3): 5.90–5.63 (m, 2H), 5.51–5.33 (m, 2H), 5.22 (dt, J = 1.5, 17.3 Hz, 1H), 5.13–5.03 (m, 2H), 4.58 (m, 1H), 3.41 (dd, J = 4.5, 6.7 Hz, 1H), 3.15 (dt, J = 4.5, 10.5 Hz, 1H), 2.52 (dd, J = 7.6, 14.3 Hz, 1H), 2.39 (dd, J = 5.2, 14.3 Hz, 1H), 1.89–1.70 (m, 2H), 1.29 (d, J = 6.0 Hz, 3H), 0.87 (s, 9H), 0.06 (s, 3H), 0.04 (s, 3H); 13C NMR (75 MHz, CDCl3): 170.5, 140.2, 132.2, 120.7, 114.7, 70.8, 68.9, 56.8, 55.5, 43.7, 34.3, 29.7, 25.7, 20.3, −4.4, −5.1; HRMS (ESI) m/z calcd for C18H32O4NaSi: [M + Na]+ 363.1962, found 363.1958.

(1S,3R,7R,10R,Z)-7-(tert-Butyldimethylsilyloxy)-3-methyl-4,11-dioxabicyclo[8.1.0]undec-8-en-5-one (26)

Grubbs’ second generation catalyst (12.4 mg, ca. 0.01 mmol) was dissolved in anhydrous, deoxygenated CH2Cl2 (50 mL) under an argon atmosphere. After the solution was heated at reflux, diene 10 (50 mg, 0.14 mmol) in dry, deoxygenated CH2Cl2 (50 mL) was added slowly (30 min) to the reaction mixture. The reaction mixture was then stirred at room temperature for an additional 4 h. After completion of the reaction, the solvent was evaporated under reduced pressure. Purification of the crude residue by silica gel column chromatography (ethyl acetate[thin space (1/6-em)]:[thin space (1/6-em)]hexane = 1[thin space (1/6-em)]:[thin space (1/6-em)]4) afforded 26 (33 mg, 74%) as a colorless viscous liquid. [α]25D −15.1 (c 1.0, CHCl3); IR (neat): 2954, 2928, 2856, 1729, 1464, 1285, 1124, 1072 cm−1; 1H NMR (300 MHz, CDCl3): 5.69 (ddd, J = 1.5, 7.5, 11.3 Hz, 1H), 5.37 (ddd, J = 1.5, 5.2, 11.3 Hz, 1H), 5.305 (m, 1H), 4.78 (m, 1H), 3.45 (m, 1H), 3.03 (dt, J = 3.7, 11.3 Hz, 1H), 2.56 (dd, J = 3.7, 10.5 Hz, 1H), 2.43 (t, J = 10.5 Hz, 1H), 2.19 (ddd, J = 1.5, 3.0, 11.3 Hz, 1H), 2.15 (m, 1H), 1.30 (d, J = 6.0 Hz, 3H), 1.26 (s, 1H), 0.90 (s, 9H), 0.11 (s, 3H), 0.10 (s, 3H); 13C NMR (75 MHz, CDCl3): 170.3, 137.4, 126.2, 67.6, 68.4, 57.2, 53.5, 44.4, 38.1, 28.7, 20.5, −4.9, −4.7; HRMS (ESI) m/z calcd for C16H29O4Si: [M + H]+ 313.1829, found 313.1827.

(R)-((R)-1-((2S,3R)-3-Vinyloxiran-2-yl)propan-2-yl)-3-hydroxypent-4-enoate (27)

Same procedure followed as mentioned for the synthesis of compound 2 given below. [α]25D −9.9 (c 1.5, CHCl3); IR (neat): 3389, 2956, 2926, 2854, 1714, 1633, 1378, 1276, 1045 cm−1; 1H NMR (300 MHz, CDCl3): 5.89 (m, 1H), 5.71 (ddd, J = 3.9, 5.9, 16.9 Hz, 1H), 5.47 (d, J = 16.9 Hz, 1H), 5.42–5.29 (m, 2H), 5.17 (m, 1H), 4.55 (m, 1H), 4.22 (m, 1H), 3.43 (dd, J = 3.4, 5.9 Hz, 1H), 3.18 (dt, J = 5.9, 10.9 Hz, 1H), 2.60–2.47 (m, 2H), 1.88–1.76 (m, 2H), 1.33 (d, J = 5.9 Hz, 3H); 13C NMR (75 MHz, CDCl3): 171.6, 138.1, 132.10, 120.8, 115.4, 69.3, 68.9, 56.8, 55.2, 41.4, 34.0, 20.1; HRMS (ESI) m/z calcd for C12H18O4Na: [M + Na]+ 249.1097, found 249.1094.

(1S,3R,7R,10R,Z)-7-Hydroxy-3-methyl-4,11-dioxabicyclo-[8.1.0]undec-8-en-5-one (2)

To a solution of 26 (20 mg, 0.06 mmol) in THF (5 mL) at 0 °C, TBAF (0.12 mL, 0.12 mmol, 1 M in THF) was added and the reaction mixture was stirred for 30 min at room temperature. After completion of the reaction (monitored by TLC), it was quenched with a saturated solution of NH4Cl (5 mL) and diluted with ethyl acetate (10 mL). The layers were separated and the aqueous layer extracted with ethyl acetate (3 × 10 mL). The combined organic layers were dried over Na2SO4 and concentrated under reduced pressure, and the crude product was purified by silica gel chromatography (ethyl acetate[thin space (1/6-em)]:[thin space (1/6-em)]hexane = 2[thin space (1/6-em)]:[thin space (1/6-em)]3) to afford 2 (12 mg, 92%) as a colorless liquid. [α]25D −139 (c 1.2, CHCl3); IR (neat): 3458, 2950, 2924, 2854, 1729, 1219 cm−1; 1H NMR (300 MHz, CDCl3): 5.72 (ddd, J = 2.0, 7.9, 11.9 Hz, 1H), 5.47 (ddd, J = 1.0, 5.9, 10.9 Hz, 1H), 5.31 (ddq, J = 1.0, 5.9, 11.9 Hz, 1H), 4.88 (m, 1H), 3.48 (m, 1H), 3.03 (dt, J = 3.9, 10.9 Hz, 1H), 2.68 (dd, J = 3.9, 10.9 Hz, 1H), 2.45 (t, J = 10.9 Hz, 1H), 2.21 (dd, J = 2.0, 13.9 Hz, 1H), 1.32 (d, J = 6.0 Hz, 3H), 1.26 (s, 1H); 13C NMR (75 MHz, CDCl3): 170.0, 135.7, 127.9, 67.8, 67.7, 57.1, 53.4, 43.5, 38.0, 20.4; HRMS (ESI) m/z calcd for C10H15O4: [M + H]+ 199.0964, found 199.0965.

Acknowledgements

D.K.M. thanks CSIR, New Delhi, for financial support as part of XII Five Year Plan Programme under title ORIGIN (CSC-0108). The authors thank Dr G. N. Sastry for helpful discussions on DFT studies. G.U. thanks the University Grants Commission (UGC), New Delhi, India, and M.M.R. thanks the Council of Scientific and Industrial Research (CSIR), New Delhi, India, for financial assistance in the form of a research fellowship.

Notes and references

  1. For review on synthetic, biosynthetic, and pharmacological aspects of decanolides, see: (a) G. Dräger, A. Kirschning, R. Thiericke and M. Zerlin, Nat. Prod. Rep., 1996, 13, 365 RSC ; (b) H. M. C. Ferraz, F. I. Bombonato and L. S. Longo Jr, Synthesis, 2007, 3261 CrossRef CAS PubMed ; (c) V. B. Riatto, R. A. Pilli and M. M. Victor, Tetrahedron, 2008, 64, 2279 CrossRef CAS PubMed .
  2. A. A. Sy, D. C. Swenson, J. B. Gloer and D. T. Wicklow, J. Nat. Prod., 2008, 71, 415 CrossRef CAS PubMed .
  3. (a) R. B. Chennakesava and H. M. Meshram, Tetrahedron Lett., 2010, 51, 4020 CrossRef PubMed ; (b) P. Radha Krishna and R. T. Jagannadha, Org. Biomol. Chem., 2010, 8, 3130 RSC .
  4. (a) D. K. Mohapatra, D. P. Reddy, U. Dash and J. S. Yadav, Tetrahedron Lett., 2011, 52, 151 CrossRef CAS PubMed ; (b) D. K. Mohapatra, R. Somaiah, M. M. Rao, F. Caijo, M. Mauduit and J. S. Yadav, Synlett, 2010, 1223 CrossRef CAS PubMed ; (c) D. K. Mohapatra, U. Dash, P. R. Naidu and J. S. Yadav, Synlett, 2009, 2129 CrossRef CAS PubMed ; (d) D. K. Mohapatra, G. Sahoo, D. K. Ramesh and G. N. Sastry, Tetrahedron Lett., 2009, 50, 5636 CrossRef CAS PubMed ; (e) D. K. Mohapatra, D. K. Ramesh, M. A. Giardello, M. S. Chorghade, M. K. Gurjar and R. H. Grubbs, Tetrahedron Lett., 2007, 48, 2621 CrossRef CAS PubMed ; (f) M. K. Gurjar, S. Karmakar and D. K. Mohapatra, Tetrahedron Lett., 2004, 45, 4525 CrossRef CAS PubMed .
  5. (a) A. Gradillas and L. Pérez-Castells, Angew. Chem., Int. Ed., 2006, 45, 6086 CrossRef CAS PubMed ; (b) A. Deiters and S. F. Martin, Chem. Rev., 2004, 104, 2199 CrossRef CAS PubMed ; (c) R. H. Grubbs, Tetrahedron, 2004, 60, 7117 CrossRef CAS PubMed ; (d) J. Prunet, Angew. Chem., Int. Ed., 2003, 42, 2826 CrossRef CAS PubMed ; (e) J. A. Love, in Handbook of Metathesis, ed. R. H. Grubbs, Wiley-VCH, Weinheim, Germany, 2003, p. 296 Search PubMed ; (f) T. M. Trnka and R. H. Grubbs, Acc. Chem. Res., 2001, 34, 18 CrossRef CAS PubMed ; (g) A. Fürstner, Angew. Chem., Int. Ed., 2000, 39, 3012 CrossRef ; (h) M. E. Maier, Angew. Chem., Int. Ed., 2000, 39, 2073 CrossRef CAS ; (i) R. H. Grubbs and S. Chang, Tetrahedron, 1998, 54, 4413 CrossRef CAS ; (j) S. K. Armstrong, J. Chem. Soc., Perkin Trans. 1, 1998, 371 RSC ; (k) K. Gerlach, M. Quitschalle and M. Kalesse, Tetrahedron Lett., 1999, 40, 3553 CrossRef CAS .
  6. (a) M. Tokunaga, J. F. Larrow, F. Kakiuchi and E. N. Jacobsen, Science, 1997, 277, 936 CrossRef CAS ; (b) S. E. Schaus, B. D. Brandes, J. F. Larrow, M. Tokunaga, K. B. Hansen, A. E. Gould, M. E. Furrow and E. N. Jacobsen, J. Am. Chem. Soc., 2002, 124, 1307 CrossRef CAS PubMed .
  7. J. S. Yadav, N. N. Kumar, M. S. Reddy and A. R. Prasad, Tetrahedron, 2007, 63, 2689 CrossRef CAS PubMed .
  8. (a) P. V. Ramachandran, M. V. Ram Reddy and H. C. Brown, Tetrahedron Lett., 2000, 41, 583 CrossRef CAS ; (b) S. Bartlett, H. D. Bose, D. Ghori and B. Mechsner, Synthesis, 2013, 1106 CAS .
  9. Y. Zhengqing, G. Tingyi and Z. Gang, Tetrahedron, 2011, 67, 5979 CrossRef PubMed .
  10. T. Seiichi, S. Yoshiaki and O. Kunio, Tetrahedron: Asymmetry, 1993, 4, 1795 CrossRef .
  11. A. D. Mico, R. Margarita, L. Parlanti, A. Vescovi and G. Piancatelli, J. Org. Chem., 1997, 62, 6974 CrossRef .
  12. J. Mulzer, A. Mantoulidis and E. Ohler, J. Org. Chem., 2000, 65, 7457 Search PubMed .
  13. B. Schmidt, O. Kunz and M. H. Peterson, J. Org. Chem., 2012, 77, 10897 CrossRef CAS PubMed .
  14. J. B. Epp and T. S. Widlanski, J. Org. Chem., 1999, 64, 293 CrossRef CAS .
  15. J. Inanaga, K. Hirata, H. Saeki, T. Katsuki and M. Yamaguchi, Bull. Chem. Soc. Jpn., 1979, 52, 1989 CrossRef CAS .
  16. M. J. Frisch, G. W. Trucks, H. B. Schlegel, G. E. Scuseria, M. A. Robb, J. R. Cheeseman, G. Scalmani, V. Barone, B. Mennucci, G. A. Petersson, H. Nakatsuji, M. Caricato, X. Li, H. P. Hratchian, A. F. Izmaylov, J. Bloino, G. Zheng, J. L. Sonnenberg, M. Hada, M. Ehara, K. Toyota, R. Fukuda, J. Hasegawa, M. Ishida, T. Nakajima, Y. Honda, O. Kitao, H. Nakai, T. Vreven, J. A. Montgomery, Jr, J. E. Peralta, F. Ogliaro, M. Bearpark, J. J. Heyd, E. Brothers, K. N. Kudin, V. N. Staroverov, T. Keith, R. Kobayashi, J. Normand, K. Raghavachari, A. Rendell, J. C. Burant, S. S. Iyengar, J. Tomasi, M. Cossi, N. Rega, J. M. Millam, M. Klene, J. E. Knox, J. B. Cross, V. Bakken, C. Adamo, J. Jaramillo, R. Gomperts, R. E. Stratmann, O. Yazyev, A. J. Austin, R. Cammi, C. Pomelli, J. W. Ochterski, R. L. Martin, K. Morokuma, V. G. Zakrzewski, G. A. Voth, P. Salvador, J. J. Dannenberg, S. Dapprich, A. D. Daniels, O. Farkas, J. B. Foresman, J. V. Ortiz, J. Cioslowski and D. J. Fox, Gaussian 09, Revision C.01, Gaussian, Inc., Wallingford CT, 2010 Search PubMed .

Footnote

Electronic supplementary information (ESI) available: Scanned copies of 1H and 13C NMR data. See DOI: 10.1039/c3ra44478c

This journal is © The Royal Society of Chemistry 2014